Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Infectious Diseases Therapeutics Market Research Reports

Titlepublishedprice

Global Clotrimazole Market Research Report 2017

By QYResearch Group
"...... et, with capacity, production, price, revenue and market share for each manufacturer, covering - Bayer - Erregierre - F.I.S. - Amoli Organics - CordenPharma - Ciron Group - Halcyon Labs - INFA G......"
03-Jan-2017$2900

Aspergillosis-Pipeline Insights, 2017

By Delve Insight
"...... Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations deta......"
01-Jan-2017$1250

Shigella Infections (Shigellosis)-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Escherichia Coli Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... a Coli Infections Report is to understand the market and pipeline status of the drugs around the Escherichia Coli Infections to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipe......"
01-Jan-2017$2000

Fungal Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... port is to understand the market and pipeline status of the drugs around the Fungal Infections to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsi......"
01-Jan-2017$2000

Mycamine -Drug Insights, 2017

By Delve Insight
"...... ovides the Mycamine sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Mycamine, patents information and exclusivity data, route of synthesis, competitive ......"
01-Jan-2017$1000

Influenza A Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... ections Report is to understand the market and pipeline status of the drugs around the Influenza A Infections to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies......"
01-Jan-2017$2000

Staphylococcal Infections-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Streptococcal Infections-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Streptococcus Pneumoniae (Pneumococcus) Infections-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Avail upto 50% Discount on below Publisher Reports.